rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sujal M. Patel

CEO, President, and Secretary

Company insider

Files Form 4 as: CEO, President, and Secretary, Nautilus Biotechnology; President & CEO, Isilon Systems.

In numbers

Trades disclosed
127
Buys
16
Sells
62
Bought
$2.2M
Sold
$8.1M
Companies
2
Companies where not an officer
0
First trade
20 Dec 2006
Last trade
4 Mar 2026
Last filed
4 Mar 2026

Companies traded

Where they are an officer
NAUT Nautilus BiotechnologyDirector, Officer, 10% owner · Life-science tools · last 4 Mar 202616 buys · 0 sells
Isilon SystemsDirector, Officer · last 21 Dec 20100 buys · 62 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Mar 2026filed 4 Mar 2026NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$65K25,000 at $2.61filing
4 Mar 2026filed 4 Mar 2026NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$65K25,000 at $2.61filing
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—650,000 at $0.00filing
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—650,000 at $0.00filing
8 Sep 2025filed 9 Sep 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$57K83,500 at $0.68filing
5 Sep 2025filed 9 Sep 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$78K116,500 at $0.67filing
20 Mar 2025filed 21 Mar 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$24K23,933 at $1.00filing
19 Mar 2025filed 21 Mar 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$53K53,300 at $0.99filing
3 Mar 2025filed 4 Mar 2025NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—650,000 at $0.00filing
11 Mar 2024filed 11 Mar 2024NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$34K12,044 at $2.84filing
8 Mar 2024filed 11 Mar 2024NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$7,2662,430 at $2.99filing
7 Mar 2024filed 7 Mar 2024NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$54K18,854 at $2.89filing
6 Mar 2024filed 7 Mar 2024NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$25K9,267 at $2.70filing
5 Mar 2024filed 7 Mar 2024NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$20K7,405 at $2.65filing
1 Mar 2024filed 5 Mar 2024NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—650,000 at $0.00filing
27 Feb 2023filed 1 Mar 2023NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—650,000 at $0.00filing
8 Aug 2022filed 8 Aug 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$24K8,346 at $2.93filing
5 Aug 2022filed 8 Aug 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$122K41,654 at $2.92filing
9 May 2022filed 10 May 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$198K50,000 at $3.96filing
4 Mar 2022filed 4 Mar 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Code M$1,000100 at $10.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care16
Not placed62

Buys in green, sells in red, by the company’s sector.

Related people

Farzad NazemDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew S. McIlwainDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew L. PosardDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Karen AkinsanyaOfficer · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Epperly Melissa BDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year